172 related articles for article (PubMed ID: 11286628)
1. Antagonistic effects of the staphylococcal enterotoxin a mutant, SEA(F47A/D227A), on psoriasis in the SCID-hu xenogeneic transplantation model.
Boehncke WH; Hardt-Weinelt K; Nilsson H; Wolter M; Dohlsten M; Ochsendorf FR; Kaufmann R; Antonsson P
J Invest Dermatol; 2001 Apr; 116(4):596-601. PubMed ID: 11286628
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
[TBL] [Abstract][Full Text] [Related]
3. Biologic effects of bacterial superantigens in a xenogeneic transplantation model for psoriasis.
Boehncke WH
J Investig Dermatol Symp Proc; 2001 Dec; 6(3):231-2. PubMed ID: 11924833
[TBL] [Abstract][Full Text] [Related]
4. A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo.
Rosendahl A; Hansson J; Antonsson P; Sékaly RP; Kalland T; Dohlsten M
Infect Immun; 1997 Dec; 65(12):5118-24. PubMed ID: 9393804
[TBL] [Abstract][Full Text] [Related]
5. Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A.
Bavari S; Dyas B; Ulrich RG
J Infect Dis; 1996 Aug; 174(2):338-45. PubMed ID: 8699064
[TBL] [Abstract][Full Text] [Related]
6. Induction of acute inflammation in vivo by staphylococcal superantigens I: Leukocyte recruitment occurs independently of T lymphocytes and major histocompatibility complex Class II molecules.
Diener K; Tessier P; Fraser J; Köntgen F; McColl SR
Lab Invest; 1998 Jun; 78(6):647-56. PubMed ID: 9645755
[TBL] [Abstract][Full Text] [Related]
7. A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.
Gidlöf C; Dohlsten M; Lando P; Kalland T; Sundström C; Tötterman TH
Blood; 1997 Mar; 89(6):2089-97. PubMed ID: 9058731
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.
Zollner TM; Podda M; Pien C; Elliott PJ; Kaufmann R; Boehncke WH
J Clin Invest; 2002 Mar; 109(5):671-9. PubMed ID: 11877475
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors.
Papageorgiou AC; Tranter HS; Acharya KR
J Mol Biol; 1998 Mar; 277(1):61-79. PubMed ID: 9514739
[TBL] [Abstract][Full Text] [Related]
10. Antibodies are capable of directing superantigen-mediated T cell killing of chronic B lymphocytic leukemia cells.
Gidlöf C; Dohlsten M; Kalland T; Tötterman TH
Leukemia; 1995 Sep; 9(9):1534-42. PubMed ID: 7544852
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcal enterotoxin-A directly stimulates signal transduction and interferon-gamma production in psoriatic T-cell lines.
Nielsen MB; Odum N; Gerwien J; Svejgaard A; Bendtzen K; Bregentholt S; Röpke C; Geisler C; Dohlsten M; Kaltoft K
Tissue Antigens; 1998 Dec; 52(6):530-8. PubMed ID: 9894851
[TBL] [Abstract][Full Text] [Related]
12. Genetically engineered superantigens as tolerable antitumor agents.
Hansson J; Ohlsson L; Persson R; Andersson G; Ilbäck NG; Litton MJ; Kalland T; Dohlsten M
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2489-94. PubMed ID: 9122222
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcal enterotoxin microbial superantigens.
Johnson HM; Russell JK; Pontzer CH
FASEB J; 1991 Sep; 5(12):2706-12. PubMed ID: 1916093
[TBL] [Abstract][Full Text] [Related]
14. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production.
Herz U; Schnoy N; Borelli S; Weigl L; Käsbohrer U; Daser A; Wahn U; Köttgen E; Renz H
J Invest Dermatol; 1998 Mar; 110(3):224-31. PubMed ID: 9506440
[TBL] [Abstract][Full Text] [Related]
15. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
16. Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma.
Tordsson JM; Ohlsson LG; Abrahmsén LB; Karlström PJ; Lando PA; Brodin TN
Cancer Immunol Immunother; 2000 Mar; 48(12):691-702. PubMed ID: 10752477
[TBL] [Abstract][Full Text] [Related]
17. The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.
Hâkansson M; Petersson K; Nilsson H; Forsberg G; Björk P; Antonsson P; Svensson LA
J Mol Biol; 2000 Sep; 302(3):527-37. PubMed ID: 10986116
[TBL] [Abstract][Full Text] [Related]
18. Induction of psoriasiform inflammation by a bacterial superantigen in the SCID-hu xenogeneic transplantation model.
Boehncke WH; Zollner TM; Dressel D; Kaufmann R
J Cutan Pathol; 1997 Jan; 24(1):1-7. PubMed ID: 9027626
[TBL] [Abstract][Full Text] [Related]
19. A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma.
Takemura S; Kudo T; Asano R; Suzuki M; Tsumoto K; Sakurai N; Katayose Y; Kodama H; Yoshida H; Ebara S; Saeki H; Imai K; Matsuno S; Kumagai I
Cancer Immunol Immunother; 2002 Mar; 51(1):33-44. PubMed ID: 11845258
[TBL] [Abstract][Full Text] [Related]
20. Activation of T cells by superantigen in class II-negative mice.
Avery AC; Markowitz JS; Grusby MJ; Glimcher LH; Cantor H
J Immunol; 1994 Dec; 153(11):4853-61. PubMed ID: 7963549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
